STD Diagnostics Market Size & Share, Growth Report 2032

STD Diagnostics Market Size - By Product Type (Instruments/Analyzers, Consumables), By Test Type (Laboratory & PoC Testing), By Disease (Syphilis, Gonorrhea, Genital Herpes, HPV, HIV/AIDS), By Technology, By End-use & Forecast, 2024 – 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definition

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3&nbsp;&nbsp;&nbsp; Data collection

1.4&nbsp;&nbsp;&nbsp; Forecast calculations

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp; Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp; Public sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Rising incidence of sexually transmitted diseases

3.2.1.2&nbsp;&nbsp;&nbsp; Growing awareness and screening programs

3.2.1.3&nbsp;&nbsp;&nbsp; Increasing research and development activities

3.2.1.4&nbsp;&nbsp;&nbsp; Technological advancements in STD diagnostics

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Stigma and sociocultural barriers

3.2.2.2&nbsp;&nbsp;&nbsp; Stringent regulatory scenario

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Technological landscape

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.6&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.6.1&nbsp;&nbsp;&nbsp; Supplier power

3.6.2&nbsp;&nbsp;&nbsp; Buyer power

3.6.3&nbsp;&nbsp;&nbsp; Threat of new entrants

3.6.4&nbsp;&nbsp;&nbsp; Threat of substitutes

3.6.5&nbsp;&nbsp;&nbsp; Industry rivalry

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.3&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.4&nbsp;&nbsp;&nbsp; Strategy outlook matrix

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product Type, 2018 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Instrument/analyzers

5.2.1&nbsp;&nbsp;&nbsp; Laboratory devices

5.2.1.1&nbsp;&nbsp;&nbsp; Thermal cyclers &ndash; PCR

5.2.1.2&nbsp;&nbsp;&nbsp; Lateral flow readers

5.2.1.3&nbsp;&nbsp;&nbsp; Flow cytometers

5.2.1.4&nbsp;&nbsp;&nbsp; Absorbance microplate reader

5.2.1.5&nbsp;&nbsp;&nbsp; Differential light scattering machines

5.2.1.6&nbsp;&nbsp;&nbsp; Other laboratory devices

5.2.2&nbsp;&nbsp;&nbsp; Point of care devices

5.2.2.1&nbsp;&nbsp;&nbsp; Phone chips (Microfludics + ICT)

5.2.2.2&nbsp;&nbsp;&nbsp; Portable/bench top/rapid diagnostic kits

5.3&nbsp;&nbsp;&nbsp; Consumables

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Test Type, 2018 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Laboratory testing

6.3&nbsp;&nbsp;&nbsp; Point of care (PoC) testing

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Disease, 2018 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG)

7.3&nbsp;&nbsp;&nbsp; Syphilis

7.4&nbsp;&nbsp;&nbsp; Gonorrhea

7.5&nbsp;&nbsp;&nbsp; Genital herpes (HSV I &amp; HSV II)

7.6&nbsp;&nbsp;&nbsp; HPV (Human papillomavirus)

7.7&nbsp;&nbsp;&nbsp; HIV/AIDS (Human immunodeficiency virus/ acquired immunodeficiency syndrome)

7.8&nbsp;&nbsp;&nbsp; Ureaplasma &amp; mycoplasma

7.9&nbsp;&nbsp;&nbsp; Trichomoniasis

7.10&nbsp;&nbsp;&nbsp; VZV (Varicella zoster virus)

7.11&nbsp;&nbsp;&nbsp; Other diseases

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Technology, 2018 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Immunoassay

8.3&nbsp;&nbsp;&nbsp; Molecular diagnostics

8.4&nbsp;&nbsp;&nbsp; Other technologies

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End-Use, 2018 &ndash; 2032 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; Hospitals &amp; clinics

9.3&nbsp;&nbsp;&nbsp; Diagnostic laboratories

9.4&nbsp;&nbsp;&nbsp; Home care testing

9.5&nbsp;&nbsp;&nbsp; Other end-users

Chapter 10&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2018 &ndash; 2032 ($ Mn)

10.1&nbsp;&nbsp;&nbsp; Key trends

10.2&nbsp;&nbsp;&nbsp; North America

10.2.1&nbsp;&nbsp;&nbsp;U.S.

10.2.2&nbsp;&nbsp;&nbsp;Canada

10.3&nbsp;&nbsp;&nbsp; Europe

10.3.1&nbsp;&nbsp;&nbsp;Germany

10.3.2&nbsp;&nbsp;&nbsp;UK

10.3.3&nbsp;&nbsp;&nbsp;France

10.3.4&nbsp;&nbsp;&nbsp;Italy

10.3.5&nbsp;&nbsp;&nbsp;Spain

10.3.6&nbsp;&nbsp;&nbsp;Rest of Europe

10.4&nbsp;&nbsp;&nbsp; Asia Pacific

10.4.1&nbsp;&nbsp;&nbsp;Japan

10.4.2&nbsp;&nbsp;&nbsp;China

10.4.3&nbsp;&nbsp;&nbsp;India

10.4.4&nbsp;&nbsp;&nbsp;Australia

10.4.5&nbsp;&nbsp;&nbsp;South Korea

10.4.6&nbsp;&nbsp;&nbsp;Rest of Asia Pacific

10.5&nbsp;&nbsp;&nbsp; Latin America

10.5.1&nbsp;&nbsp;&nbsp;Brazil

10.5.2&nbsp;&nbsp;&nbsp;Mexico

10.5.3&nbsp;&nbsp;&nbsp;Argentina

10.5.4&nbsp;&nbsp;&nbsp;Rest of Latin America

10.6&nbsp;&nbsp;&nbsp; Middle East and Africa

10.6.1&nbsp;&nbsp;&nbsp;Saudi Arabia

10.6.2&nbsp;&nbsp;&nbsp;South Africa

10.6.3&nbsp;&nbsp;&nbsp;UAE

10.6.4&nbsp;&nbsp;&nbsp;Rest of Middle East and Africa

Chapter 11&nbsp;&nbsp;&nbsp;Company Profiles

11.1&nbsp;&nbsp;&nbsp; Abbott Laboratories

11.2&nbsp;&nbsp;&nbsp; Becton, Dickinson and Company

11.3&nbsp;&nbsp;&nbsp; bioMerieux SA

11.4&nbsp;&nbsp;&nbsp; Bio-Rad Laboratories, Inc.

11.5&nbsp;&nbsp;&nbsp; Danaher Corporation

11.6&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche Ltd

11.7&nbsp;&nbsp;&nbsp; Hologic, Inc.

11.8&nbsp;&nbsp;&nbsp; QIAGEN N.V.

11.9&nbsp;&nbsp;&nbsp; Seegene Inc.

11.10&nbsp;&nbsp;&nbsp; Siemens Healthineers AG

11.11&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific Inc.

11.12&nbsp;&nbsp;&nbsp; Trinity Biotech plc 
&nbsp;

STD Diagnostics Market

Get a free sample of this report